Skip to main content

GWM Advisors LLC

SEC CIK
0001633516
Latest filing
Aug 12, 2026

HZNP holding history

Horizon Therapeutics Public Ltd Co in every 13F filed by GWM Advisors LLC, including the quarters it was sold out or no filing was made. Changes compare share counts with the previous calendar quarter.

HZNP overviewAll 13F holders of HZNPFull Q2 2026 holdings

Shares (Q4 2023)
0
Sold out in Q4 2023
Value
$0
% of portfolio
0.0%
Quarters held
10
Since Q1 2021
Holdings of HZNP by GWM Advisors LLC, by quarter
QuarterSharesValue% of portfolioShare changeActionAll holders
Q4 20230$00.0%−800−100.0%Sold outHolders
Q3 2023800$92.6K<0.1%−454−36.2%ReducedHolders
Q2 20231,254$129.0K<0.1%+206+19.7%AddedHolders
Q1 20231,048$114.4K<0.1%−446−29.9%ReducedHolders
Q4 20221,494$56.3K<0.1%−5,525−78.7%ReducedHolders
Q3 20227,019$434.0K<0.1%−910−11.5%ReducedHolders
Q2 20227,929$632.0K<0.1%+7,929NewHolders
Q1 20220$00.0%−8,340−100.0%Sold outHolders
Q4 20218,340$899.0K<0.1%−2,510−23.1%ReducedHolders
Q3 202110,850$1.19M<0.1%+425+4.1%AddedHolders
Q2 202110,425$976.0K<0.1%+6,275+151.2%AddedHolders
Q1 20214,150$382.0K<0.1%––Holders

Livermore's 13F data starts with Q1 2021, so Q1 2021 has no change from the previous quarter.